ClinicalTrials.Veeva

Menu

Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Unknown
Phase 1

Conditions

Cocaine-Related Disorders

Treatments

Drug: Cocaine (IV)

Study type

Interventional

Funder types

NIH

Identifiers

NCT00094315
NIDA-CTO-0014-1

Details and patient eligibility

About

To study of classical conditioning mechanisms associated with arousal, craving and cocaine use.

Full description

This is a single-site, double-blind, placebo-controlled crossover study of classical conditioning mechanisms associated with arousal, craving and cocaine use.

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Be English-speaking volunteers who are cocaine dependent
  • Be non-treatment seeking at the time of the study
  • Meet DSM-IV criteria for cocaine dependence
  • Have ECG showing normal sinus rhythm, normal conductivity, and non clinically significant arrhythmias
  • Females must provide a negative pregnancy test and agree to use birth control
  • Have baseline laboratory tests within normal limits

Exclusion criteria

  • Please contact site for more information

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems